Remove BioTech Remove Health Policy Remove Study Remove Survey
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 160
article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

Here, we call out the 12% increase in the proportion of Americans who say that parents should be able to choose not to vaccinate their children, found in the Kaiser Family Foundation COVID-19 Vaccine Monitor survey from December 2022. There is another data point in the study on women’s health and prescriptions — for ADHD drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

rank prescription drugs, lab tests, emergency room visits, dental and vision care, preventive services, chronic disease management and mental health care as the “most essential” health care services, according to the 2019 Survey of America’s Patients conducted by The Physicians Foundation. People in the U.S.

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

For more color, read Jane’s April 2008 report, “The Wisdom of Patients,” where she wrote about PLM in its start-up phase (see section on page 20 entitled “ An Ongoing, Live Outcomes Study ”). When this occurred, it didn’t cause more than a ripple of interest outside biotech. A 2018 national survey found that 39% of U.S.

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

The study was written up by Beth Snyder Bulik in FiercePharma. Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Among the top 20 in this study were two pharma brands — Pfizer and AstraZeneca.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

Nine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today. A majority of people across political party share this concern: overall, 88% of U.S. 84% of Republicans. 84% of Republicans.

BioTech 191
article thumbnail

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

There is one health care public policy issue that unites U.S. The survey was fielded in June 2021 among 1,071 U.S. In this study, the researchers identified the following costs by stakeholder: For patients, out-of-pocket expenses, including payments for deductibles, copayments, and coinsurance amounts.